- Asbestos Exposure
- Consumer Fraud
- Human Rights
- Medical Devices
- Medical Drugs
- Nursing Home Abuse & Neglect
- Personal Injury & Wrongful Death
- Securities Class Actions
- Toxic Exposure
Motley Rice is accepting clients who need legal guidance submitting their claims to the new 9/11 Victim Compensation Fund. If you or a loved one suffered from a physical injury, illness or death potentially connected to 9/11 toxic exposure or debris removal and would like to discuss a potential claim, contact Jodi Westbrook Flowers by email or call 1.800.768.4026.
Named “The James Zadroga 9/11 Health and Compensation Act of 2010” in honor of the late James Zadroga—a New York City police officer and 9/11 first responder whose death from respiratory disease was the first attributed to 9/11 toxin exposure—the Zadroga Act broadens the scope of the Victim Compensation Fund, enabling more people who suffered physical injury, illness or death as a result of the 9/11 attacks to obtain economic relief through the program.
Among those eligible for the new 9/11 Victim Compensation Fund (VCF II) are:
In response to these horrific acts of terrorism on September 11, 2001, the United States government opened the original September 11 Victim Compensation Fund (VCF I). This fund went to support the children, parents and spouses left behind by the 9/11 victims and was closed in 2004. Nine years after 9/11, the fund was re-authorized by Congress and reopened in response to the growing number of first responders, clean-up workers and residents who began suffering from a number of different illnesses, including cancer and lung diseases, and dying years after being exposed to toxic chemicals and carcinogens at the attack sites. The 9/11 VCF continues to operate today.
In a decision announced just one day before the 11th commemoration of 9/11, federal authorities added 58 types of cancers to the list of illnesses covered by the new Victim Compensation Fund. These cancers include, among others:
The full extent of health consequences resulting from 9/11 toxic exposure are still unknown, but many victims have been diagnosed with health problems such as:
On Feb. 1, 2014, the WTC Health Program announced it will consider certain blood or bone marrow disorders as covered health conditions that are eligible to members for treatment. As in past additions by the WTC Health Program, we anticipate the 9/11 VCF to consider these modifications to the list of covered conditions.
Please note that if you already applied to the original Fund and received compensation for your injuries, you may not be eligible to re-apply to the new Victim Compensation Fund unless you can show that your injuries have substantially worsened or are different, new injuries.
On Dec. 18, 2015, Congress passed and President Obama signed into law the reauthorization of the James Zadroga Health and Compensation Act of 2010. As such, the September 11th Victim Compensation Fund will remain open for another five years. Claimants who have been issued an award determination will begin to receive their full payments in the coming months, and the VCF is still open for new claimant registration. Registration deadlines include the following:
The new 9/11 Victim Compensation fund also established the World Trade Center Health Program (WTC Health Program) for the purpose of providing “medical monitoring and treatment for responders at the WTC and related sites in New York City, the Pentagon, and Shanksville, PA, and survivors who were in the New York City disaster area.” The WTC Health Program provides valuable research regarding the health impacts of the 9/11 attacks and regularly updates the types of conditions eligible for treatment under the program.
In the consolidated lawsuit In re September 11 Litigation, Motley Rice anti-terrorism lawyers represented and settled the claims of 56 of the 96 families who opted out of the original 9/11 VCF to pursue claims against aviation and security companies. In addition to providing greater answers, accountability and recourse to victims' families, the litigation helped provide public access to evidence in an archive of selected discovery materials gathered in the litigation.